Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited financial results ....

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 29th July 2026 Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Ref.: Scrip Code: BSE: 530549 & NSE: SHILPAMED Dear Sir, Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we hereby wish to inform you that the Meeting of the Board of Directors of Shilpa Medicare Limited is scheduled to be held on Wednesday, 05 August 2026 inter alia to consider and approve unaudited financial results of the company for the quarter ended 30 June, 2026. In terms of the Code of Conduct for Prevention of Insider Trading in securities of the Company, the Trading Window has been closed with effect from 01 July 2026 and remains closed up to 48 hours after the declaration of unaudited financial results of the Company for the quarter ended 30 June 2026. A copy of this intimation is also being made available at: https://www.vbshilpa.com/stock-exchange-intimations.php This is for your information and records. Yours faithfully, For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer